Evidence map›Paper›PMID 38918834›Full record

ArticleRadiation oncology (London, England)2024

Quantitative parameter analysis of pretreatment dual-energy computed tomography in nasopharyngeal carcinoma cervical lymph node characteristics and prediction of radiotherapy sensitivity.

Zhiru Li, Chao Li, Liyan Li, Dong Yang, Shuangyue Wang, Junmei Song, Muliang Jiang, Min Kang

Abstract read
In one paragraph

Article in Radiation oncology (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhiru Li *Department of Oncology, Sichuan Provincial People's Hospital·Qionglai Medical Center Hospital, Chengdu, Sichuan, People's Republic of China.
Chao Li *Department of Obstetrics and Gynecology, Sichuan Provincial People's Hospital·Qionglai Medical Center Hospital, Chengdu, Sichuan, People's Republic of China.
Liyan LiDepartment of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Dong YangDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, Guangxi, Guangxi, 530021, People's Republic of China.
Shuangyue WangDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, Guangxi, Guangxi, 530021, People's Republic of China.
Junmei SongDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, Guangxi, Guangxi, 530021, People's Republic of China.
Muliang JiangDepartment of Radiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China. jmlgxmu@gmail.com.
Min KangDepartment of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning, Guangxi, Guangxi, 530021, People's Republic of China. kangmin@gxmu.edu.cn.

Funding

Medical research project of Chengdu Health Commission No.2023406Sichuan Medical Association Youth Innovation Research Project No.Q23075the National Natural Science Foundation of China 82272736the Research Foundation of the Health Department of Guangxi Province, China S2018087The Research Foundation of the Science and Technology Department of Guangxi Province, China 2023GXNSFDA02600The Research Foundation of the Science and Technology Department of Guangxi Province, China, 2016GXNSFAA380252
6 · The paper itself

Abstract

backgroundTreatment efficacy may differ among patients with nasopharyngeal carcinoma (NPC) at similar tumor-node-metastasis stages. Moreover, end-of-treatment tumor regression is a reliable indicator of treatment sensitivity. This study aimed to investigate whether quantitative dual-energy computed tomography (DECT) parameters could predict sensitivity to neck-lymph node radiotherapy in patients with NPC.

methodsOverall, 388 lymph nodes were collected from 98 patients with NPC who underwent pretreatment DECT. The patients were divided into complete response (CR) and partial response (PR) groups. Clinical characteristics and quantitative DECT parameters were compared between the groups, and the optimal predictive ability of each parameter was determined using receiver operating characteristic (ROC) analysis. A nomogram prediction model was constructed and validated using univariate and binary logistic regression.

resultsDECT parameters were higher in the CR group than in the PR group. The iodine concentration (IC), normalized IC, Mix-0.6, spectral Hounsfield unit curve slope, effective atomic number, and virtual monoenergetic images were significantly different between the groups. The area under the ROC curve of the DECT parameters was 0.73-0.77. Based on the binary logistic regression, a column chart was constructed using 10 predictive factors, including age, sex, N stage, maximum lymph node diameter, arterial phase NIC, venous phase NIC, λHU and spectral Hounsfield units at 70 keV. The area under the ROC curve value of the constructed model was 0.813, with a sensitivity and specificity of 85.6% and 81.3%, respectively.

conclusionQuantitative DECT parameters could effectively predict the sensitivity of NPC to radiotherapy. Therefore, DECT parameters and NPC clinical features can be combined to construct a nomogram with high predictive power and used as a clinical analytical tool.

Indexed as

Lymph NodesNasopharyngeal CarcinomaNasopharyngeal NeoplasmsTomography, X-Ray ComputedAdultAgedFemaleHumansLymphatic MetastasisMaleMiddle AgedNeckNomogramsPrognosisRadiography, Dual-Energy Scanned ProjectionRetrospective StudiesDual-energy CTLymph nodesNasopharyngeal carcinomaRadiotherapy sensitivity

Identifiers

PMID38918834
PMCPMC11200824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.